Skip to main content

Table 5 Changes in the severity of CTS in the two groups after treatment

From: Safety and efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial

Group

Condition

Normal

N(%)

Mild

N(%)

Moderate

N(%)

Control

Before

0(0%)

15 (75%)

5 (25%)

After

0(0%)

16 (80%)

14 (20%)

Treat

Before

0(0%)

12 (57%)

9(43%)

After

3(14%)

10(48%)

8 (38%)